MPS Pharma Ltd. - Research Center
531686 ADVIKLA Group (XT) BSE data
Add to watchlist
| Results |
Annual
|
| Statement | |
| More |
Annual results in brief
(Rs crore)
| Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | |
|---|---|---|---|---|---|
| Sales | - | 0.03 | - | - | 0.83 |
| Operating profit | -0.95 | -0.68 | -4.13 | -0.68 | -0.72 |
| Interest | - | - | - | - | - |
| Gross profit | -0.93 | -0.42 | -3.94 | -0.66 | -0.71 |
| EPS (Rs) | -0.55 | -0.07 | -2.31 | -0.61 | -0.65 |
Annual
results in details
| Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | |
|---|---|---|---|---|---|
| Other income | 0.02 | 0.26 | 0.20 | 0.02 | 0.02 |
| Stock adjustment | - | - | - | - | - |
| Raw material | 0.05 | 0.02 | - | - | - |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 0.49 | 0.42 | 0.40 | 0.45 | 0.49 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 0.42 | 0.27 | 3.73 | 0.23 | 1.06 |
| Provisions made | - | - | - | - | - |
| Depreciation | 0.15 | 0.51 | 0.56 | 0.57 | 0.59 |
| Taxation | -0.02 | -0.79 | -0.08 | -0.07 | -0.05 |
| Net profit / loss | -1.05 | -0.14 | -4.42 | -1.17 | -1.25 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 19.11 | 19.11 | 19.11 | 19.11 | 19.11 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | - | -2,086.42 | - | - | -86.81 |
| GPM (%) | - | -144.15 | - | - | -83.42 |
| NPM (%) | - | -48.73 | - | - | -147.44 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis